Ocugen, Inc. (OCGN)

1.44 +0.04 (+2.86%) USD  |  NASDAQ  |  Dec 24, 10:44
More

Ocugen SG&A Expense (TTM): 27.76M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for OCGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Pfizer Inc. 13.91B
Belite Bio, Inc. 29.58M
MannKind Corp. 195.42M
Vertex Pharmaceuticals, Inc. 1.644B
CorMedix, Inc. 75.56M